Attached files
| file | filename |
|---|---|
| 8-K - AGGX 8-K 04/10/17 - AngioGenex, Inc. | aggx8k_041017apg.htm |
Exhibit 16.1
April 10, 2017
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington DC 20549-7561
Re:
AngioGenex, Inc.
Commission File Number: 000-26181
Commissioners:
We have read Item 4.01 of Form 8-K dated April 10, 2017, of AngioGenex, Inc. and are in agreement with the statements contained therein insofar as they relate to our firm.
Very truly yours,
/s/ Li and Company, PC
Li and Company, PC